Price alert —
Sign in to get a one-time email the moment ATAI crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · ATAI
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.0B | $-0.0B | $-0.0B | $-0.0B | -3121.8% | -3161.3% |
| 2025-12-31 | $0.0B | $-0.5B | $-0.0B | $-0.0B | -51108.2% | -3691.7% |
| 2025-09-30 | $0.0B | $-0.1B | $-0.0B | $-0.0B | -8154.1% | -3792.7% |
| 2025-06-30 | $0.0B | $-0.0B | $-0.0B | $-0.0B | -3856.6% | -3511.1% |
| 2025-03-31 | $0.0B | $-0.0B | $-0.0B | $-0.0B | -1699.7% | -1308.2% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare ATAI vs peers
Line ATAI up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with ATAI
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 19 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-03-06 | -1.73 | -0.11 | -1441.6% | +14.8% |
| 2025-11-12 | -0.28 | -0.12 | -125.3% | -4.6% |
| 2025-08-14 | -0.14 | -0.12 | -18.3% | -3.2% |
| 2025-05-14 | -0.15 | -0.18 | +16.7% | +14.0% |
| 2025-03-17 | -0.24 | -0.15 | -60.0% | -7.5% |
| 2024-11-13 | -0.16 | -0.16 | — | +1.5% |
| 2024-08-13 | -0.36 | -0.16 | -129.8% | -4.1% |
| 2024-05-15 | -0.17 | -0.18 | +5.6% | -9.3% |
| 2024-03-28 | -0.12 | -0.16 | +26.1% | -5.6% |
| 2023-11-14 | 0.25 | -0.20 | +226.6% | -4.4% |
| 2023-08-10 | -0.21 | -0.21 | -1.6% | -1.8% |
| 2023-05-11 | -0.21 | -0.22 | +3.4% | -3.1% |
| 2023-03-24 | -0.28 | -0.23 | -23.3% | +9.6% |
| 2022-11-10 | -0.22 | -0.24 | +8.1% | -6.1% |
| 2022-08-15 | -0.24 | -0.24 | +0.1% | +1.9% |
| 2022-05-16 | -0.24 | -0.25 | +5.7% | +2.0% |
| 2022-03-30 | -0.62 | -0.25 | -150.8% | -4.7% |
| 2021-11-15 | -0.21 | -0.22 | +6.5% | -4.4% |
| 2021-08-16 | -0.37 | -0.17 | -115.3% | +4.3% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| ATAI ★ | $3B | — | -15.8 | 765.8 | -20.0 | 13.3 | — | -38.7% | — | -2.08% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 17.17%
| Holder | Shares | % out |
|---|---|---|
| Deep Track Capital, Lp | 12,000,000 | 3.26% |
| Vanguard Capital Management LLC | 11,761,398 | 3.19% |
| UBS Group AG | 7,426,867 | 2.02% |
| Blackrock Inc. | 6,835,300 | 1.86% |
| Adage Capital Partners GP L.L.C. | 5,642,758 | 1.53% |
| Susquehanna International Group, LLP | 5,286,326 | 1.44% |
| Millennium Management Llc | 4,364,096 | 1.19% |
| Morgan Stanley | 3,852,772 | 1.05% |
| Candriam S.C.A. | 3,086,379 | 0.84% |
| Qube Research & Technologies Ltd | 2,891,942 | 0.79% |
Insider activity · 90d
9 buys / 1 sells · ratio 9.0 · Finnhub
- HERSHBERG ROBERT M 404,869
- HERSHBERG ROBERT M 48,858
- HERSHBERG ROBERT SELL 100,000 @ $4.96
- HERSHBERG ROBERT M 100,000 @ $1.35
- HERSHBERG ROBERT M 48,858 @ $1.35
- Hoffman John Francis BUY 121,968
- Angermayer Christian BUY 121,968
- Smiley Andrea Heslin BUY 121,968
- Braunstein Scott BUY 86,095
- Braunstein Scott BUY 121,968
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-07-16 | 8-K | view · |
| 4 | 2026-07-09 | FORM 4 | view · |
| 4 | 2026-06-29 | FORM 4 | view · |
| 4 | 2026-06-29 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 4 | 2026-06-08 | FORM 4 | view · |
| 8-K | 2026-06-08 | 8-K | view · |
| 8-K | 2026-06-03 | 8-K | view · |
| 10-Q | 2026-05-12 | 10-Q | view · |
| 8-K | 2026-05-12 | 8-K | view · |
| 4 | 2026-04-22 | FORM 4 | view · |
| DEF 14A | 2026-04-22 | DEF 14A | view · |
| 4 | 2026-04-10 | FORM 4 | view · |
| 4 | 2026-03-24 | FORM 4 | view · |
| 4 | 2026-03-13 | FORM 4 | view · |
| 8-K | 2026-03-09 | 8-K | view · |
| 8-K | 2026-03-06 | 8-K | view · |
| 10-K | 2026-03-06 | 10-K | view · |
| 8-K | 2026-03-06 | 8-K | view · |
| 8-K | 2026-02-26 | 8-K | view · |
| 8-K | 2026-02-19 | 8-K | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 8-K | 2026-01-08 | 8-K | view · |
| 4 | 2026-01-06 | FORM 4 | view · |
About ATAI
AtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as Atai Beckley N.V. and…
Options picks · ATAI
ITM + OTM ideas from the latest scanLoading…
Congress trades · ATAI
STOCK Act disclosuresLoading…
SEC filings & insiders · ATAI
EDGAR · liveLoading…
Holders · ATAI
Institutions & insider activityLoading…